ADOPTIVE IMMUNOTHERAPY OF HUMAN CANCER USING LOW-DOSE RECOMBINANT INTERLEUKIN-2 AND LYMPHOKINE-ACTIVATED KILLER CELLS

被引：0
|
作者：
SCHOOF, DD
GRAMOLINI, BA
DAVIDSON, DL
MASSARO, AF
WILSON, RE
EBERLEIN, TJ
机构：
[1] BRIGHAM & WOMENS HOSP,DEPT SURG,DIV SURG ONCOL,75 FRANCIS ST,BOSTON,MA 02115
[2] HARVARD UNIV,SCH MED,BOSTON,MA 02115
来源：
CANCER RESEARCH | 1988年 / 48卷 / 17期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：5007 / 5010
页数：4
相关论文
共 50 条
  • [1] IMMUNOTHERAPY OF CANCER WITH LYMPHOKINE-ACTIVATED KILLER CELLS AND RECOMBINANT INTERLEUKIN-2
    ROSENBERG, SA
    MULE, JJ
    SURGERY, 1985, 98 (03) : 437 - 444
  • [2] LABORATORY CORRELATES OF ADOPTIVE IMMUNOTHERAPY WITH RECOMBINANT INTERLEUKIN-2 AND LYMPHOKINE-ACTIVATED KILLER CELLS IN HUMANS
    BOLDT, DH
    MILLS, BJ
    GEMLO, BT
    HOLDEN, H
    MIER, J
    PAIETTA, E
    MCMANNIS, JD
    ESCOBEDO, LV
    SNIECINSKI, I
    RAYNER, AA
    HAWKINS, MJ
    ATKINS, MB
    CIOBANU, N
    ELLIS, TM
    CANCER RESEARCH, 1988, 48 (15) : 4409 - 4416
  • [3] THE ADOPTIVE IMMUNOTHERAPY OF CANCER USING LYMPHOKINE ACTIVATED KILLER-CELLS AND RECOMBINANT INTERLEUKIN-2
    ETTINGHAUSEN, SE
    ROSENBERG, SA
    SPRINGER SEMINARS IN IMMUNOPATHOLOGY, 1986, 9 (01): : 51 - 71
  • [4] IMMUNOMODULATORY EFFECTS OF SYSTEMIC LOW-DOSE RECOMBINANT INTERLEUKIN-2 AND LYMPHOKINE-ACTIVATED KILLER CELLS IN HUMANS
    EBERLEIN, TJ
    RODRICK, ML
    MASSARO, AF
    JUNG, SE
    MANNICK, JA
    SCHOOF, DD
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 1989, 30 (03) : 145 - 150
  • [5] ADOPTIVE IMMUNOTHERAPY OF A RAT GLIOMA USING LYMPHOKINE-ACTIVATED KILLER-CELLS AND INTERLEUKIN-2
    TZENG, JJ
    BARTH, RF
    CLENDENON, NR
    GORDON, WA
    CANCER RESEARCH, 1990, 50 (14) : 4338 - 4343
  • [6] INTERSTITIAL NEPHRITIS IN A PATIENT RECEIVING ADOPTIVE IMMUNOTHERAPY WITH RECOMBINANT INTERLEUKIN-2 AND LYMPHOKINE-ACTIVATED KILLER-CELLS
    FEINFELD, DA
    DAGATI, V
    DUTCHER, JP
    WERFEL, SB
    LYNN, RI
    WIERNIK, PH
    AMERICAN JOURNAL OF NEPHROLOGY, 1991, 11 (06) : 489 - 492
  • [7] TOXICITY OF IMMUNOTHERAPY WITH INTERLEUKIN-2 AND LYMPHOKINE-ACTIVATED KILLER CELLS
    MIER, JW
    ARONSON, FR
    NUMEROF, RP
    VACHINO, G
    ATKINS, MB
    PATHOLOGY AND IMMUNOPATHOLOGY RESEARCH, 1988, 7 (06): : 459 - 476
  • [8] REGIONAL ADOPTIVE IMMUNOTHERAPY WITH INTERLEUKIN-2 AND LYMPHOKINE-ACTIVATED KILLER (LAK) CELLS FOR LIVER METASTASES
    KEILHOLZ, U
    SCHEIBENBOGEN, C
    BRADO, M
    GEORGI, P
    MACLACHLAN, D
    BRADO, B
    HUNSTEIN, W
    EUROPEAN JOURNAL OF CANCER, 1994, 30A (01) : 103 - 105
  • [9] ADOPTIVE IMMUNOTHERAPY USING LYMPHOKINE-ACTIVATED KILLER CELLS
    FOWLER, JE
    JOURNAL OF UROLOGY, 1988, 139 (01): : 148 - 149
  • [10] ADOPTIVE IMMUNOTHERAPY WITH LYMPHOKINE-ACTIVATED KILLER CELLS PLUS RECOMBINANT INTERLEUKIN-2 IN PATIENTS WITH UNRESECTABLE HEPATOCELLULAR-CARCINOMA
    ONISHI, S
    SAIBARA, T
    FUJIKAWA, M
    SAKAEDA, H
    MATSUURA, Y
    MATSUNAGA, Y
    YAMAMOTO, Y
    HEPATOLOGY, 1989, 10 (03) : 349 - 353
12345